Uric acid concentration in subjects at risk of type 2 diabetes mellitus:: Relationship to components of the metabolic syndrome

被引:157
作者
Costa, A
Igualá, I
Bedini, J
Quintó, L
Conget, I
机构
[1] Univ Barcelona, Fac Med, Hosp Clin, Serv Endocrinol & Diabet, Barcelona 08036, Spain
[2] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin,Unitat Epidemiol & Biostadist, Ctr Diagnost Biomed,Serv Bioquim, Barcelona 08036, Spain
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2002年 / 51卷 / 03期
关键词
D O I
10.1053/meta.2002.30523
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
High uric acid concentration is a common finding in subjects with risk factors for cardiovascular disease (CVD), including some characteristics of the metabolic syndrome. However, its exact role in this setting and in the progression to type 2 diabetes mellitus (DM) is not well understood and could be affected by confounding factors such as hypertriglyceridemia. Our study aimed to establish the relationship between uric acid (avoiding the interference of high triglyceride levels), insulin sensitivity, and components of the metabolic syndrome in a group of subjects at high risk of developing DM. Among 201 subjects included in the study, 111 (55.2%) showed an abnormal oral glucose tolerance and uric acid levels higher than those measured in subjects with normal glucose tolerance. Body mass index (BMI), triglycerides, diastolic blood pressure (DBP), and 2-hour glycemia in the oral glucose tolerance test (OGTT) contributed independently to uric acid concentration (R-2 = .59). However, uric acid did not affect either insulin sensitivity or glucose tolerance. The recovery tests revealed that a triglyceride concentration greater than or equal to 3 mmol/L interfered with the measurement of uric acid level when a colorimetric method was used, but not when a dry-chemistry method was used. In conclusion, uric acid concentration is higher in subjects at high risk of DM with abnormal glucose tolerance and is independently determined by various components of the metabolic syndrome. Copyright (C) 2002 by W.B. Saunders Company.
引用
收藏
页码:372 / 375
页数:4
相关论文
共 21 条
[1]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]
2-S
[3]
[Anonymous], 1991, INTERFEROGRAPHS USER
[4]
BENGTSSON C, 1988, ACTA MED SCAND, V224, P549
[5]
HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[6]
Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen - Exploring the natural history of type 2 diabetes [J].
Chou, PS ;
Li, CL ;
Wu, GS ;
Tsai, ST .
DIABETES CARE, 1998, 21 (07) :1183-1187
[7]
Costa A, 1999, DIABETIC MED, V16, P528
[8]
Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[9]
RELATIONSHIP BETWEEN RESISTANCE TO INSULIN-MEDIATED GLUCOSE-UPTAKE, URINARY URIC-ACID CLEARANCE, AND PLASMA URIC-ACID CONCENTRATION [J].
FACCHINI, F ;
CHEN, YDI ;
HOLLENBECK, CB ;
REAVEN, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :3008-3011
[10]
Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410